Responses
Clinical/translational cancer immunotherapy
Original research
Prediction of severe immune-related adverse events requiring hospital admission in patients on immune checkpoint inhibitors: study of a population level insurance claims database from the USA
Compose a Response to This Article
Other responses
No responses have been published for this article.